W. Umstead John

Insider Reports History

Entity
Individual
Location
C/O G1 Therapeutics, Inc., 700 Park Offices Drive, Suite 200, Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by W. Umstead John:

Stock Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Chief Financial Officer Common Stock 0 $0 $2.51 Sep 18, 2024 Direct
G1 Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 0 Sep 18, 2024 Direct

Insider Reports Filed by W. Umstead John

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GTHX G1 Therapeutics, Inc. Sep 18, 2024 5 $0 4 Sep 18, 2024 Chief Financial Officer
GTHX G1 Therapeutics, Inc. Jul 5, 2024 1 -$1.32K 4 Jul 8, 2024 Chief Financial Officer
GTHX G1 Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 Chief Financial Officer
GTHX G1 Therapeutics, Inc. May 13, 2024 1 -$39K 4 May 15, 2024 Chief Financial Officer
GTHX G1 Therapeutics, Inc. Mar 20, 2024 1 $0 4 Mar 22, 2024 Chief Financial Officer
GTHX G1 Therapeutics, Inc. Mar 18, 2024 1 -$19.8K 4 Mar 20, 2024 Chief Financial Officer
GTHX G1 Therapeutics, Inc. Jan 3, 2024 5 -$2.3K 4 Jan 8, 2024 Chief Financial Officer
GTHX G1 Therapeutics, Inc. May 10, 2023 1 $0 4 May 12, 2023 Chief Financial Officer
GTHX G1 Therapeutics, Inc. Mar 15, 2023 2 $0 4 Mar 17, 2023 Chief Financial Officer
GTHX G1 Therapeutics, Inc. Mar 15, 2023 0 $0 3 Mar 17, 2023 Chief Financial Officer